Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-01-001455
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
2
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y45562e10-q.txt 10-Q 67054
2 CERTIFICATE OF INCORPORATION, AS AMENDED y45562ex3-1.txt EX-3.1 66241
  Complete submission text file 0000950123-01-001455.txt   135003
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 1545978
SIC: 2835 In Vitro & In Vivo Diagnostic Substances